Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	442.33	137.64	298.4	171.45	130.24	89.51
Short-Term Investments	-	-	-	19.82	10.04	5.01
Cash & Short-Term Investments	442.33	137.64	298.4	191.27	140.28	94.52
Cash Growth	265.65%	-53.87%	56.01%	36.35%	48.41%	76.73%
Accounts Receivable	58.27	53.65	10.79	6.72	6.42	10.54
Receivables	58.27	53.65	10.79	6.72	6.42	10.54
Inventory	20.02	15.64	6.81	7.87	4.65	1.96
Prepaid Expenses	17.88	12.05	4.32	3.92	7.45	3.83
Other Current Assets	0.51	0.35	0.49	0.33	0.45	0.52
Total Current Assets	539	219.33	320.81	210.11	159.24	111.36
Property, Plant & Equipment	3.68	3.7	3.62	3.98	0.13	1
Long-Term Investments	14.84	16.49	-	-	-	-
Other Intangible Assets	166.02	194.05	32.47	-	-	-
Long-Term Deferred Tax Assets	48.47	36.54	18.74	23.7	32.97	-
Other Long-Term Assets	-	-	-	0.01	0.01	0.01
Total Assets	772.01	470.11	375.63	237.79	192.35	112.38
Accounts Payable	11.56	14.8	3.98	2.77	4.26	4.12
Accrued Expenses	42.66	40.29	27.83	21.95	17.4	17.09
Current Portion of Leases	0.39	0.37	0.34	0.31	0.03	0.3
Current Income Taxes Payable	-	0.73	8.7	0.08	-	1.53
Other Current Liabilities	50.78	19.88	16.75	1.96	1.07	1.06
Total Current Liabilities	105.4	76.06	57.59	27.06	22.76	24.1
Long-Term Leases	2.89	3.19	3.56	3.89	-	0.65
Other Long-Term Liabilities	2.79	2.98	14.06	-	-	-
Total Liabilities	111.07	82.23	75.21	30.96	22.76	24.75
Common Stock	0.12	0.11	0.11	0.1	0.1	0.1
Additional Paid-In Capital	431.6	266.49	250.43	233.19	223.17	216.21
Retained Earnings	229.23	121.27	49.86	-26.31	-53.71	-128.69
Comprehensive Income & Other	-	0.01	0.02	-0.15	0.03	0.01
Shareholders' Equity	660.94	387.88	300.42	206.83	169.6	87.63
Total Liabilities & Equity	772.01	470.11	375.63	237.79	192.35	112.38
Total Debt	3.28	3.56	3.89	4.2	0.03	0.95
Net Cash (Debt)	439.05	134.08	294.5	187.06	140.25	93.57
Net Cash Growth	274.21%	-54.47%	57.43%	33.38%	49.89%	74.96%
Net Cash Per Share	3.60	1.18	2.64	1.74	1.32	0.88
Filing Date Shares Outstanding	119.27	117.86	105.65	102.74	103.82	103.41
Total Common Shares Outstanding	119.27	107.12	105.26	102.99	103.78	103.4
Working Capital	433.6	143.27	263.22	183.04	136.49	87.26
Book Value Per Share	5.54	3.62	2.85	2.01	1.63	0.85
Tangible Book Value	494.93	193.83	267.95	206.83	169.6	87.63
Tangible Book Value Per Share	4.15	1.81	2.55	2.01	1.63	0.85
Machinery	0.96	0.49	0.27	0.25	0.29	-
Leasehold Improvements	0.99	0.99	0.98	0.98	0.18	-

Source: S&P Capital IQ. Standard template. Financial Sources.